跳至主要内容
临床试验/CTRI/2025/09/095273
CTRI/2025/09/095273尚未招募不适用

European Registry On Plaque ModifiCAtion in the STEMI Population (ROCA-STEMI)

NA1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年10月7日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
NA
入组人数
200
试验地点
1
主要终点
Target Vessel Failure The occurrence of cardiac death, target vessel myocardial infraction and target vessel revascularization

研究概览

简要总结

This is an European prospective cohort study from February 2023 until February 2026 The investigators want to analyze the clinical success, efficacy and safety of consecutive patients who presented with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention for de novo heavily calcified culprit lesion using plaque modification devices before stent implantation

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Diagnosis of STEMI Undergoing primary PCI De novo culprit lesion in a native coronary artery Severe calcification of the target lesion or equivalent balloon uncrossable or undilatable lesion Use of a plaque modification device to treat the culprit lesion Signed written informed consent by the patient or their legal representative.

排除标准

  • The target vessel had a stent from a previous PCI The target lesion was treated as a staged procedure Pregnant women Terminally ill patients.

结局指标

主要结局

Target Vessel Failure The occurrence of cardiac death, target vessel myocardial infraction and target vessel revascularization

时间窗: 12 Months

次要结局

  • Cardiac death Death that could not be attributed to a noncardiac etiology was considered cardiac death

研究者

发起方
NA
申办方类型
Other []
责任方
Principal Investigator
主要研究者

Dr Sarita Rao

Department of Cardiology 5th floor Apollo Rajshree Hospitals Sector-D Scheme No 74C Vijay Nagar Indore Madhya Pradesh 452010

研究点 (1)

Loading locations...

相似试验